|
SLC37A3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.43138842392909E-14 |
| Normal-vs-Stage2 |
9.039600E-04 |
| Normal-vs-Stage3 |
4.800500E-04 |
| Normal-vs-Stage4 |
1.657840E-02 |
| Stage1-vs-Stage2 |
3.228400E-01 |
| Stage1-vs-Stage3 |
6.655000E-01 |
| Stage1-vs-Stage4 |
5.613200E-01 |
| Stage2-vs-Stage3 |
6.143400E-01 |
| Stage2-vs-Stage4 |
2.456800E-01 |
| Stage3-vs-Stage4 |
4.850200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.70070002314793E-09 |
| Normal-vs-Asian |
7.317500E-02 |
| Caucasian-vs-AfricanAmerican |
6.874400E-01 |
| Caucasian-vs-Asian |
8.748200E-01 |
| AfricanAmerican-vs-Asian |
7.956600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
3.58730045668665E-10 |
| Male-vs-Female |
3.204400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.68520000024486E-07 |
| Normal-vs-Extreme_Weight |
1.43499656601875E-11 |
| Normal-vs-Obese |
1.07579944952363E-10 |
| Normal-vs-Extreme_Obese |
6.567900E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.124600E-01 |
| Normal_Weight-vs-Obese |
5.300200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.335200E-01 |
| Extreme_Weight-vs-Obese |
7.999800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.192800E-01 |
| Obese-vs-Extreme_Obese |
5.599600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.83589999999523E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
9.08384478748303E-13 |
| Normal-vs-Age(81-100Yrs) |
3.073600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.416200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.151000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.835200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.782200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.531000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.629800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
3.994400E-04 |
| Normal-VS-KIRP CIMP |
2.363700E-02 |
| Normal-VS-Unclassified PRCC |
4.12389999999707E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.88780005358791E-09 |
| Type1 PRCC-VS-KIRP CIMP |
1.312950E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.825600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.744400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.466100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.365000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.09169999999937E-05 |
| Normal-vs-N1 |
2.841200E-04 |
| Normal-vs-N2 |
2.009700E-02 |
| N0-vs-N1 |
1.781390E-01 |
| N0-vs-N2 |
7.953000E-01 |
| N1-vs-N2 |
4.205000E-01 |
|
|
